chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 08-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 (also reported as "l003188" and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 552 hours and the lowest recorded temperature reported was 27 Fahrenheit (F) (-2.777777778 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 06-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23, 0.5 ml, which had a lot # of L003188 (also reported as "l003188" and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 504 hours and the lowest recorded temperature reported as 27 Fahrenheit (F) (-2.777777778 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 26-JUN-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 32 hours and the lowest recorded temperature reported as 34 Fahrenheit (F) (1.111111111 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HBHEPB
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via company representative, concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 25-JUL-2016, the patient was vaccinated with an improperly stored dose of COMVAX (lot number J013884; expiration date 19-AUG-2016) 0.5 ml "SDV;PK/10 (route of administration and anatomical location were not reported). On an unspecified dates, the COMVAX had nine temperature excursion: 88 hours, 1456 hours, 64 hours, 232 hours, 328 hours, 72 hours, 64 hours, 40 hours and 488 hours. The lowest recorded temperature was 28 F (-2.222222222 Celsius) while the highest recorded temperature was 478F (8.888888889 Celsius). No adverse effects reported and no product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 23-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 (also reported as "l003188" and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 912 hours and the lowest recorded temperature reported was 27 Fahrenheit (F) (-2.777777778 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 30-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23, 0.5 ml, which had a lot # of L003188 (also reported as "l003188" and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 1080 hours and the lowest recorded temperature reported was 27 Fahrenheit (F) (-2.777777778 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 24-AUG-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 and an expiration date of 02-JAN-2000 (route and anatomical location of administration were not reported). The sum of hours in excursion was 1680 hours and the lowest recorded temperature reported was 27 Fahrenheit (F) (-2.777777778 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 14-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 64 hours and the lowest recorded temperature reported were 31 and 34 Fahrenheit (F) -0.555555556 and 1.111111111 Celsius (C)) respectively. The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 08-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 64 and 32 hours and the lowest recorded temperature reported was 34 and 31 Fahrenheit (F) (1.11111111 and -0.555555556 Celsius (C)) respectively. The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HBHEPB
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via company representative, concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 22-JUL-2016, the patient was vaccinated with an improperly stored dose of COMVAX (lot number J013884; expiration date 19-AUG-2016) 0.5 ml (route of administration and anatomical location were not reported). On an unspecified dates, the COMVAX had five temperature excursions: 64 hours, 1456 hours, 232 hours, 64 hours and 88 hours. The lowest recorded temperature was 3028 F (-1.111111111 Celsius). No adverse effects reported and no product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 01-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 64 hours and the lowest recorded temperature reported was 34 Fahrenheit (F) (1.111111111 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator (R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 25-JUN-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 8 hours and the lowest recorded temperature reported was 34 Fahrenheit (F) (1.111111111 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 25-JUN-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 (also reported as "l003188" and an expiration date of 20-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 168 and 24 hours and the highest recorded temperature reported was 49 and 47 Fahrenheit (F) (9.44444444 and 8.333333333 Celsius (C)) respectively. The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 08-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 64 and 32 hours and the lowest recorded temperature reported were 34 and 31 Fahrenheit (F) (1.111111111 and -0.555555556 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator (R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 29-JUN-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 64 hours and the lowest recorded temperature reported was 34 Fahrenheit (F) (1.111111111 Celsius (C)).. The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 14-OCT-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23, 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 200, 24, 132 and 352 hours and the lowest recorded temperature reported were 32, 33, 34, and 29 Fahrenheit (F) (0, 0.555555556, 1.111111111 and -1.666666667 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 13-OCT-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 328, 200, 24 and 132 hours and the lowest recorded temperature reported were 29, 32, 33 and 34 Fahrenheit (F) (-1.666666667, 0, 0.555555556 and, 1.111111111 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 24-AUG-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23, 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion was 16 hours and the lowest recorded temperature reported as 33 Fahrenheit (F) (0.555555556 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 09-SEP-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 24, 108 and 192 hours and the lowest recorded temperature reported were 33, 34 and 32 Fahrenheit (F) (0.555555556, 1.111111111 and 0 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator (R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor Quality Product Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 08-OCT-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 208, 200, 24 and 132 hours and the lowest recorded temperature reported were 29, 32, 33 and 34 Fahrenheit (F) (-1.666666667, 0, 0.555555556 and 1.11111111 Celsius (C)) respectively. The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HBHEPB
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via company representative, concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 09-NOV-2015, the patient was vaccinated with an improperly stored dose of COMVAX (lot number J013884; expiration date 19-AUG-2016) 0.5 ml "SDV;PK/10" (route of administration and anatomical location were not reported). On an unspecified dates, the COMVAX had nine temperature excursions: 64 hours, 152 hours, 976 hours, 40 hours, 488 hours, 88 hours, 328 hours, 72 hours and 64 hours. The lowest recorded temperature was 28 F (-2.222222222 Celsius) while the highest recorded temperature was 48 F (8.388888889 Celsius). No adverse effects reported and no product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator (R)".This is one of several cases from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 17-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds .5 mLVIs 10 SDV, which had the lot # K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 88, 344, 168, 152, 184 and 264 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree), 31 F (-0.555555556 Celsius degree), 33 F (0.555555556 Celsius degree), 30 F (-1.1111111111 Celsius degree) 29 F (-1.666666667), 32 F (0 Celsius degrees) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of several reports received from the same reporter. Additional information has beenrequested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 29-OCT-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds .5 mL Vls 10 SDV, which had the lot # K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 88, 64, 320, 152, 184 and 264 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree), 33 F (0.555555556 Celsius degree), 31 F (-0.555555556 Celsius degree), 30 F (-1.111111111 Celsius degree), 29 F (-1.666666667 Celsius degree) and 32 F (0 Celsius degrees) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator (R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 17-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, which had the lot # K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 264, 168, 184, 152, 344 and 88 hours. The lowest recorded temperature was 32 F (0 Celsius degrees), 33 F (0.555555556 Celsius degree), 29 F (-1.666666667 Celsius degree), 30 F (-1.111111111 Celsius degree), 31 F (-0.555555556 Celsius degree) and 34 F (1.111111111 Celsius degree) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 09-OCT-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, which had the lot# K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 200, 320, 128, 120, 64 and 88 hours. The lowest recorded temperature was 32 F (0 Celsius degrees), 31 F (-0.555555556 Celsius degree), 30 F (-1.111111111 Celsius degree), 29 F (-1.666666667 Celsius degree), 33 F (0.555555556 Celsius degree), 34 F (1.111111111 Celsius degree) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 11-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds .5 mLVIs 10 SDV, which had the lot # K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 184, 264, 152, 88, 152 and 344 hours. The lowest recorded temperature was 29 F (1.666666667 Celsius degree), 32 F (0 Celsius degree), 30 F (-1.1111111111 Celsius degree), 34 F (1.111111111 Celsius degree) 33 F (0.555555556) and 31 F (-0.555555556 Celsius degrees) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 29-OCT-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, which had the lot # K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 88, 64, 264, 184, 152 and 320 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree), 33 F (0.555555556 Celsius degree), 32 F (0 Celsius degrees), 29 F (-1.66666667 Celsius degree), 30 F (-1.111111111 Celsius degree), 31 F (-0.555555556 Celsius degree) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown demographics. Information regarding the patient's concurrent conditions and medical history was not provided. On 07-NOV-2016, the patient was inadvertently vaccinated with an expired dose of (wistar ra 27-3) M-M-R II which had a lot number of K018990 and expiration date on 15-OCT-2016 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medication was not reported. On 20-JUL-2015, the patient was vaccinated with an improperly stored dose of VAQTA 10 Pk 25 U/0.5 ml SD Llok w Cap Ped, which had the lot # L001445, with expiration date 15-FEB-2016 (dose, dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On an unspecified date the vaccine experienced a temperature excursions of 24 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree). The vaccine status was reports as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 17-JUN-2015, the patient was vaccinated with an improperly stored dose of VAQTA, which had the lot # L001445, with expiration date 15-FEB-2016 (dose, dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On an unspecified date the vaccine experienced a temperature excursions of 24 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree). The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HBHEPB
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via company representative, concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 27-OCT-2014, the patient was vaccinated with an improperly stored dose of COMVAX (lot number J013884; expiration date 19-AUG-2016) 0.5 ml (route of administration and anatomical location were not reported). On an unspecified dates, the COMVAX had two temperature excursions, one of 72 hours and 40 hours. The lowest recorded temperature was 28 F (-2.222222222 Celsius) while the highest recorded temperature was 47 F (8.333333333 Celsius). No adverse effects reported and no product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's medical history, drug reactions or allergies and concomitant medications was not reported. On 02-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, which had the lot # K008409, with expiration date 04-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced different temperature excursions of 88, 64, 184, 152, 264 and 328 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree), 33 F (0.555555556 Celsius degree), 29 F (-1.666666667 Celsius degree), 30 F (-1.111111111 Celsius degree), 32 F (0 Celsius degrees), 31 F (-0.555555556 Celsius degree) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medications was not reported. On 18-MAR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, which had the lot # K010465, with the expiration date 23-MAR-2016 (dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced temperature excursions of 16 hours. The lowest recorded temperature was 33 F (0.555555556 Celsius degree). The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Feeling cold, Headache, Influenza like illness, Pain in extremity
Clinical narrative: 11/8 Flu like symptoms, chills, headache, sore arm, red, redness spread to elbow. Red underarm painful.
Age: 45.0
Sex: F
Vaccine: PER, TTOX
Symptoms: Computerised tomogram, Electronystagmogram, Nuclear magnetic resonance imaging, Pain in extremity, Rotator cuff syndrome
Clinical narrative: Received a tetanus shot with whooping cough vaccine two days later Right arm began hurting went to ER received pain meds Went to reg. DR.
Age: 9.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: High Fever that lasted for 3 days around 103-104 degrees. Body Aches. Chills.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Musculoskeletal stiffness
Clinical narrative: Stiffness, severe tenderness from injection site radiating up shoulder to neck and down from injection site to elbow, lasting greater than 48 hrs.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Insomnia, Mobility decreased, Musculoskeletal pain, Pain
Clinical narrative: At time of injection, the pain was very severe. I kept saying ouch over and over. Once needle was removed there was no initial pain.  Not sure exactly of time of onset but within hours I had severe pain in shoulder.  I couldn't raise my arm without pain and was unable to sleep at all that night.  On Monday (11/7/2016) I went back to pharmacy to speak to another pharmacist.  He said this happens sometimes and will go away.  I am now in day 11 and the pain did ease up slightly for awhile but returned yesterday again very bad pain.  I have been taking Advils since the shot, using a heating pad and icing the shoulder.  It does not seem to be helping.  I will be calling my doctor on Monday (11/14/16) to make her aware of the problem.   I hope this will go away.  I still cannot even lift my left arm up half way without pain.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test, Pain, Pain in extremity, Ultrasound scan normal, X-ray limb
Clinical narrative: Extreme pain from upper arm radiating downward to hand & wrist. Pain with/without movement.
Age: 33.0
Sex: F
Vaccine: FLUX
Symptoms: Bedridden, Chills, Confusional state, Cough, Delirium
Clinical narrative: On 11/10/2016, got a low grade fever, chills, and muscle weakness. By evening 11/11/2016, my fever was much higher, confused, delirious, and bed ridden due to fatigue and muscle aches. On 11/12/2016, my fever broke, going back to low grade temperatures with sporadic chills but a persistent violent and unproductive cough has lingered to today the 11/13/2016.
Age: 33.0
Sex: F
Vaccine: FLUX
Symptoms: Fatigue, Muscular weakness, Myalgia, Pyrexia
Clinical narrative: On 11/10/2016, got a low grade fever, chills, and muscle weakness. By evening 11/11/2016, my fever was much higher, confused, delirious, and bed ridden due to fatigue and muscle aches. On 11/12/2016, my fever broke, going back to low grade temperatures with sporadic chills but a persistent violent and unproductive cough has lingered to today the 11/13/2016.
Age: 60.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Headache
Clinical narrative: Severe pain in joints and severe headache that lasted 48 hours, almost bad enough to go to ER.  Acetaminophen did not relieve.  Slight relieve with aspirin.
Age: 37.0
Sex: F
Vaccine: FLUX
Symptoms: Discomfort, Nausea, Pain
Clinical narrative: Slight Nausea, body aches in multiple areas that was bad enough it required me to take a few breaths to encourage my body to move. Discomfort brought me to tears. Eventually took Motrin which helped a little. Next day symptoms began to diminish.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Swelling
Clinical narrative: Redness in area, swelling.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Blood test, Blood test abnormal, Computerised tomogram, Condition aggravated, Dysphagia
Clinical narrative: On 10/20/15, I visited my family physician, who prescribed some medications for my sinus and respiratory distress. On 11/6/15, I visited my Cardiologist, who confirmed I did not have a heart issue. On 11/7/15, I again went to Hospital, because I swallowed a large pill that got caught in my throat and went into my lung. I was now having difficulty swallowing and beginning to lose weight. Fortunately, I was able to cough up the pill. On 11/10 and 11/15, I went to my Pulmonologist for an X-rays of my Lungs and then a reading of the X-rays. The Pulmonologist said my lungs were not the cause of the breathing difficulty. He also suggested that I continue the sinus medications and visit an ENT doctor. The first available appointment for my ENT was December 12, 2015. During the time between this appointment and the ENT appointment, my ability to swallow decreased dramatically. I had to cut food smaller and smaller and eventually, I could only eat cereals like Cream of Wheat. On 12/11/2015, I went to an ENT doctor, and after an extensive office visit, he recommended that I see a neurologist as soon as possible. On 12/12/2015, I was in severe respiratory distress and my daughter took me to Hospital for evaluation and testing because of my persistent sinus issue and respiratory distress. Some of the evaluation tests completed at Hospital included an MRl, CT scan, and an Endoscopy, various blood tests plus others. I was told by various doctors at Hospital that perhaps I had a sinus infection, or a severe allergic reaction to one of my long term blood pressure medications or a DVT among other possibilities. I was admitted to hospital and moved from the ER to an observation room to continue my medical evaluation. However, my condition continued to deteriorate and on December 16, I was transferred to an ICU room at Hospital and placed on a ventilator with a suspected diagnosis of Myasthenia Gravis. On 12/18/2015, I was transferred to another hospital to a Neurological ICU for further examination. During my time there I underwent several tests to rule out different diagnostics. On 12/28/2015, because of continued respiratory distress and difficulty swallowing I received a Tracheostomy, a PEG tube and IVIG infusions (over several days) while in the ICU. On 1/4/2016, the results of a blood test taken at another Hospital confirmed the originally suspected diagnosis of Myasthenia Gravis. On 1/6/2016, I was transferred by ambulance to rehab because I needed oxygen, suctioning for my Trach, training on how to use my feeding tube, and rehabilitation to help me relearn how to walk and talk again. On 1/28/2016, I was released from Rehab to continue my rehabilitation at home using the service of Rehab's home health care services. These services were specifically for physical, speech and occupational therapy as well as the services of a visiting nurse. These services lasted approximately 6 to 8 week depending on my progress on each service. Speech therapy took the longest.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Endoscopy, Gait disturbance, Gastrostomy, General physical health deterioration, Immunoglobulin therapy
Clinical narrative: On 10/20/15, I visited my family physician, who prescribed some medications for my sinus and respiratory distress. On 11/6/15, I visited my Cardiologist, who confirmed I did not have a heart issue. On 11/7/15, I again went to Hospital, because I swallowed a large pill that got caught in my throat and went into my lung. I was now having difficulty swallowing and beginning to lose weight. Fortunately, I was able to cough up the pill. On 11/10 and 11/15, I went to my Pulmonologist for an X-rays of my Lungs and then a reading of the X-rays. The Pulmonologist said my lungs were not the cause of the breathing difficulty. He also suggested that I continue the sinus medications and visit an ENT doctor. The first available appointment for my ENT was December 12, 2015. During the time between this appointment and the ENT appointment, my ability to swallow decreased dramatically. I had to cut food smaller and smaller and eventually, I could only eat cereals like Cream of Wheat. On 12/11/2015, I went to an ENT doctor, and after an extensive office visit, he recommended that I see a neurologist as soon as possible. On 12/12/2015, I was in severe respiratory distress and my daughter took me to Hospital for evaluation and testing because of my persistent sinus issue and respiratory distress. Some of the evaluation tests completed at Hospital included an MRl, CT scan, and an Endoscopy, various blood tests plus others. I was told by various doctors at Hospital that perhaps I had a sinus infection, or a severe allergic reaction to one of my long term blood pressure medications or a DVT among other possibilities. I was admitted to hospital and moved from the ER to an observation room to continue my medical evaluation. However, my condition continued to deteriorate and on December 16, I was transferred to an ICU room at Hospital and placed on a ventilator with a suspected diagnosis of Myasthenia Gravis. On 12/18/2015, I was transferred to another hospital to a Neurological ICU for further examination. During my time there I underwent several tests to rule out different diagnostics. On 12/28/2015, because of continued respiratory distress and difficulty swallowing I received a Tracheostomy, a PEG tube and IVIG infusions (over several days) while in the ICU. On 1/4/2016, the results of a blood test taken at another Hospital confirmed the originally suspected diagnosis of Myasthenia Gravis. On 1/6/2016, I was transferred by ambulance to rehab because I needed oxygen, suctioning for my Trach, training on how to use my feeding tube, and rehabilitation to help me relearn how to walk and talk again. On 1/28/2016, I was released from Rehab to continue my rehabilitation at home using the service of Rehab's home health care services. These services were specifically for physical, speech and occupational therapy as well as the services of a visiting nurse. These services lasted approximately 6 to 8 week depending on my progress on each service. Speech therapy took the longest.